Finally, chronic lung disease in the setting of SJIA and MAS has been increasingly recognized in the past decade, in parallel with widespread use of anti-cytokine (IL-1 and IL-6) biologics [12–14]. This evidence concerns the gene IL1B and chronic lung disease.